FORT LAUDERDALE-DAVIE, Fla. – Nova Southeastern University (NSU) President and CEO George L. Hanbury II, Ph.D., recently announced the appointment of H. Thomas Temple, M.D., as senior vice president of translational research and economic development for the university.
This new position was created to support the university’s innovative faculty within its colleges, centers and institutes in the development of their ideas, discoveries and technologies. In his role, Dr. Temple is responsible for building the connections, resources and entrepreneurial energy for the commercialization of NSU’s research activities.
To accomplish this, Dr. Temple will establish partnerships with companies, investors and entrepreneurs interested in utilizing NSU’s vast wet and dry lab space and state-of-the-art Center for Collaborative Research (opening spring of 2016) to conduct research and develop technologies that will benefit the global community. Additionally, Dr. Temple will be bridging the research efforts conducted through the CCR with NSU’s Oceanographic Center, headquartered at the Guy Harvey Oceanographic Center in Hollywood, Fla. Dr. Temple’s position represents a partnership with HCA East Florida hospitals where he has been granted privileges and will maintain a surgical practice complementing his role with NSU.
“Dr. Temple has a long-established reputation as a successful surgeon, researcher and leader,” said NSU’s President Hanbury. “As NSU nears the completion of its vast Center for Collaborative Research and is taking the necessary steps to add a teaching and research hospital on our campus, it is essential for us to focus on building and establishing strategic business and research partnerships. These efforts will add $500 million to NSU’s current $2.6 billion economic impact from the creation of new patents, licenses and enterprises and the expansion of existing companies.”
Located on NSU’s main campus in Davie, Florida, the 215,000-square-foot, $80 million Center for Collaborative Research (CCR) will provide wet labs for many of NSU’s cutting edge research as well as its General Clinical Research Center, an outpatient facility providing a centralized clinical research infrastructure to benefit investigators in multiple disciplines. The CCR will also be home to NSU’s Institute for Neuro-Immune Medicine; the Rumbaugh-Goodwin Institute for Cancer Research; the Emil Buehler Research Center for Engineering, Science and Mathematics; and the U.S. Geological Survey.
Dr. Temple’s medical career spans nearly three decades. He joins NSU from the University of Miami Miller School of Medicine, where he served most recently as chief of the Orthopaedic Oncology Division, director of the University of Miami Tissue Bank, professor of orthopaedics and pathology and vice-chairman of the Department of Orthopaedics.
Dr. Temple’s clinical interests are novel treatment of benign and malignant bone and soft tissue tumors in children and adults, tissue transplantation and complex limb reconstruction. His research interests are stem cell applications in bone and cartilage regeneration, tissue banking and developing targeted therapies for sarcomas.
Dr. Temple earned his Bachelor of Arts degree from Harvard University in Cambridge, Mass., and his Doctor of Medicine from Jefferson Medical College in Philadelphia. He completed his residency in orthopaedic surgery at Walter Reed Army Medical Center in Washington, D.C., and his musculoskeletal oncology fellowship at Harvard University/Massachusetts General Hospital/Boston Children’s Hospital in Boston.
Dr. Temple is board certified by the American Board of Orthopaedic Surgery.